Medical News

RSS

Pfizer's Xalkori receives FDA approval to treat late-stage NSCLC patients with abnormal ALK gene

The U.S. Food and Drug Administration today approved Xalkori (crizotinib) to treat certain patients with late-stage (locally advanced or metastatic), non-small cell lung cancers (NSCLC) who express the abnormal anaplastic lymphoma kinase (ALK) gene.

29 Aug 2011

Individuals with BAP1 gene mutation more likely to develop mesothelioma

Scientists have found that individuals who carry a mutation in a gene called BAP1 are susceptible to developing two forms of cancer - mesothelioma, and melanoma of the eye.

29 Aug 2011

ELIQUIS better than warfarin in reduction of stroke, major bleeding, and mortality

Bristol-Myers Squibb Company and Pfizer Inc. today announced the main results of the Phase 3 clinical trial ARISTOTLE, which evaluated ELIQUIS compared to warfarin for the prevention of stroke or systemic embolism in 18,201 patients with atrial fibrillation and at least one risk factor for stroke.

29 Aug 2011

AAO-HNSF's 2011 Annual Meeting & OTO EXPO to convene in San Francisco

The 2011 Annual Meeting & OTO EXPO of the American Academy of Otolaryngology - Head and Neck Surgery Foundation (AAO-HNSF), the largest meeting of ear, nose, and throat doctors in the world, will convene September 11-14, 2011, in San Francisco, CA.

29 Aug 2011

MitraClip treatment could benefit heart failure patients who are unresponsive to CRT

Results of an observational study presented at the European Society of Cardiology (ESC) meeting today in Paris demonstrate that the percutaneous catheter-based MitraClip treatment improves symptoms and promotes reverse left ventricular (LV) remodeling in patients with mitral regurgitation (MR), who do not respond to cardiac resynchronization therapy.

29 Aug 2011

Strong link between leisure-time physical activity and AF among men

A Norwegian survey carried out between 1974 and 2003 showed that there was a graded independent increase in the risk of AF with increasing levels of physical activity in a population-based study among men with ostensibly no other heart disease. In women the data were inconclusive.

29 Aug 2011

QIAGEN acquires Cellestis

QIAGEN N.V. today announced that its acquisition of all the ordinary shares in Cellestis Limited by a way of a scheme of arrangement has been implemented.

From QIAGEN Manchester Limited 29 Aug 2011

New clinical data shows positive long-term performance of Medtronic's CoreValve system

New clinical data presented today at the European Society of Cardiology Congress 2011 demonstrate positive long-term performance for the CoreValve transcatheter aortic valve replacement system from Medtronic, Inc.

From Medtronic 29 Aug 2011

Low-cost device to help physicians detect and diagnose cancer

An engineering researcher and a global health expert from Michigan State University are working on bringing a low-cost, hand-held device to nations with limited resources to help physicians detect and diagnose cancer.

29 Aug 2011

U.S. medical costs linked with treatment of preventable diseases to reach $66B per year

The rising prevalence of obesity around the globe places an increasing burden on the health of populations, on healthcare systems and on overall economies. A major challenge for researchers is to quantify the effect of these burdens to inform public policies.

29 Aug 2011

Colchicine more effective than placebo for recurrent pericarditis

Colchicine, when given in addition to conventional therapy, was more effective than placebo in reducing the incidence of recurrence and the persistence of symptoms of pericarditis in a randomised controlled trial.

29 Aug 2011

Scientists identify six new genetic variants associated with type 2 diabetes in South Asians

An international team of researchers led by Imperial College London has identified six new genetic variants associated with type-2 diabetes in South Asians. The findings, published in Nature Genetics, give scientists new leads in the search for diagnostic markers and drug targets to prevent and treat this major disease.

29 Aug 2011

LUNGevity Foundation applauds FDA's recent approval of XALKORI lung cancer drug

LUNGevity Foundation applauds the US Food and Drug Administration's (FDA) recent approval of XALKORI (crizotinib) to treat lung cancer. The drug, introduced by Pfizer, Inc. showed such promise in early trials that it was given "fast track" status by the FDA.

29 Aug 2011

States experimenting with Medicaid managed care

Some states are seeing managed care as a way to save money on their Medicaid programs, according to news coverage.

29 Aug 2011

CPSC, USFA offer safety tips after Hurricane Irene strikes

The U.S. Consumer Product Safety Commission (CPSC) and U.S. Fire Administration (USFA) are warning residents in hurricane-impacted areas about the deadly dangers that can remain even after Hurricane Irene strikes.

29 Aug 2011

QLI, author of 'The Steve Jobs Way' sign licensing agreement for new training program

Quantum Learning, Inc. (QLI), a research-based provider of advanced sales and marketing training programs, and Jay Elliot, author of the book "The Steve Jobs Way" http://www.thestevejobsway.com, jointly announced today a licensing agreement.

29 Aug 2011

Astellas seeks regulatory approval for mirabegron to treat overactive bladder in the U.S., Europe

Astellas Pharma Inc. today announced the submission of a New Drug Application and Market Authorisation Application for mirabegron to the U.S. Food and Drug Administration and the European Medicines Agency.

29 Aug 2011

CIRM approves stem cell research planning grants for five UC Davis teams

The California Institute for Regenerative Medicine (CIRM), the state stem cell agency, today approved research planning grants for five UC Davis Health System teams that are working to develop human clinical trials to treat illnesses such as Huntington's disease, vascular disease, osteoporosis, HIV/AIDS and airway disease in children.

29 Aug 2011

GOP trying to turn Medicare, health reform law into political gain

"Republicans are accusing Democrats of using 'scare tactics' to convince Americans the GOP wants an end to Medicare and Social Security. In the party's weekly radio address, Sen. Dean Heller of Nevada says both parties should come together to fix those programs ... 'Let's stop the lies about who wants to end Medicare or eliminate Social Security and fix both programs now,' Heller says".

29 Aug 2011

Apixaban superior to warfarin in preventing stroke and systemic embolism

A large-scale trial finds that apixaban, a new anticoagulant drug, is superior to the standard drug warfarin for preventing stroke and systemic embolism in patients with atrial fibrillation.

29 Aug 2011

Medical News

Pfizer's Xalkori receives FDA approval to treat late-stage NSCLC patients with abnormal ALK gene

Individuals with BAP1 gene mutation more likely to develop mesothelioma

ELIQUIS better than warfarin in reduction of stroke, major bleeding, and mortality

AAO-HNSF's 2011 Annual Meeting & OTO EXPO to convene in San Francisco

MitraClip treatment could benefit heart failure patients who are unresponsive to CRT

Strong link between leisure-time physical activity and AF among men

QIAGEN acquires Cellestis

New clinical data shows positive long-term performance of Medtronic's CoreValve system

Low-cost device to help physicians detect and diagnose cancer

U.S. medical costs linked with treatment of preventable diseases to reach $66B per year

Colchicine more effective than placebo for recurrent pericarditis

Scientists identify six new genetic variants associated with type 2 diabetes in South Asians

LUNGevity Foundation applauds FDA's recent approval of XALKORI lung cancer drug

States experimenting with Medicaid managed care

CPSC, USFA offer safety tips after Hurricane Irene strikes

QLI, author of 'The Steve Jobs Way' sign licensing agreement for new training program

Astellas seeks regulatory approval for mirabegron to treat overactive bladder in the U.S., Europe

CIRM approves stem cell research planning grants for five UC Davis teams

GOP trying to turn Medicare, health reform law into political gain

Apixaban superior to warfarin in preventing stroke and systemic embolism

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Latest News